Cepheid (NASDAQ:CPHD)

CAPS Rating: 3 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Recs

0
Player Avatar fastop (< 20) Submitted: 9/9/2008 3:33:24 PM : Outperform Start Price: $15.94 CPHD Score: +131.28

Will return to glory by Q1 09 imo.

Featured Broker Partners


Advertisement